These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus. Epstein A, Barland P. Arthritis Rheum; 1985 Feb; 28(2):158-62. PubMed ID: 3882094 [Abstract] [Full Text] [Related]
3. The clinical application of an ELISA technique for the detection of antihistone antibodies. Epstein A, Greenberg M, Halbert S, Kramer L, Barland P. J Rheumatol; 1986 Apr; 13(2):304-7. PubMed ID: 3522897 [Abstract] [Full Text] [Related]
4. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA. N Engl J Med; 1978 May 25; 298(21):1157-9. PubMed ID: 306574 [Abstract] [Full Text] [Related]
6. The role of histones as nuclear autoantigens in drug-related lupus erythematosus. Tan EM, Portanova JP. Arthritis Rheum; 1981 Aug 25; 24(8):1064-9. PubMed ID: 7025842 [Abstract] [Full Text] [Related]
18. Procainamide-induced lupus erythematosus. Clinical and laboratory observations. Blomgren SE, Condemi JJ, Vaughan JH. Am J Med; 1972 Mar 25; 52(3):338-48. PubMed ID: 4536815 [No Abstract] [Full Text] [Related]
19. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus. Dixon JA, Mulhern LM, Whiteside TL, Luksick J. J Rheumatol; 1980 Mar 25; 7(4):544-6. PubMed ID: 6999152 [Abstract] [Full Text] [Related]
20. Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide. Mongey AB, Sim E, Risch A, Hess E. J Rheumatol; 1999 Aug 25; 26(8):1721-6. PubMed ID: 10451068 [Abstract] [Full Text] [Related] Page: [Next] [New Search]